Latest items of seller

[url=https://www.rootsanalysis.com/reports/view_document/neoantigen-targeted-therapies-market-2019-2030/257.html]Neoantigen Targeted Therapies Market[/url] is estimated to be worth USD 3 Billion in 2030, predicts Roots Analysis Roots Analysis is pleased to announce the publication of its recent study, titled, “Neoantig...

[url=https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html]Fragment-Based Drug Discovery Market[/url] is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based D...

[url=https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html]Oligonucleotide Synthesis, Modification and Purification Services Market[/url] is estimated to be worth USD 5.8 billion in 2030, predicts Roots Analysis The applications of oligonucleotides are vast, even beyond the life science...

Roots Analysis is pleased to announce the publication of its recent study, titled, “Neoantigen Targeted Therapies Market, 2021-2030.” [url=https://www.rootsanalysis.com/reports/view_document/neoantigen-targeted-therapies-market-2019-2030/257.html]Neoantigen Targeted Therapies Market[/url] is estimated to be worth USD 3...

[url=https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html]In Silico Drug Discovery Services Market[/url] is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis Roots Analysis is pleased to announce the publication of its recent study...

[url=https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html]Human Microbiome-based Products Market [/url]is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis Over the years, extensive R&D efforts have enabled microbiome-based ther...

Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing Roots Analysis is pleased to announce the publication of its recent study, titled...

Presently, there are more than 10 approved gene therapies; over 465 product candidates are being evaluated for the treatment of a variety of disease indications Encouraging clinical results across various metabolic, hematological and ophthalmic disorders have inspired research groups across the world to focus their eff...